Triple

T31019840
Position Surface form Disambiguated ID Type / Status
Subject Ivarest E790422 entity
Predicate instanceOf P0 FINISHED
Object anti-itch medication C7482 CONCEPT FINISHED

How this triple was built (1 step)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

CD Concept disambiguation gpt-5-mini-2025-08-07
Target class: anti-itch medication
Context triple: [Ivarest, instanceOf, anti-itch medication]
  • A. H1 receptor antagonist
    An H1 receptor antagonist is a drug that selectively blocks histamine H1 receptors to reduce or prevent allergic symptoms such as itching, sneezing, and hives.
  • B. medication chosen
    A medication is a substance or combination of substances administered to diagnose, treat, prevent, or alleviate symptoms of disease or medical conditions in humans or animals.
  • C. antidote
    An antidote is a substance or treatment that counteracts or neutralizes the effects of a poison, toxin, or harmful agent in a living organism.
  • D. anti-dandruff shampoo
    An anti-dandruff shampoo is a medicated hair cleanser formulated with active ingredients to reduce flaking, itching, and irritation of the scalp caused by dandruff.
  • E. azole antifungal
    Azole antifungals are a class of drugs that inhibit fungal ergosterol synthesis by blocking cytochrome P450–dependent 14α-demethylase, thereby disrupting cell membrane formation and treating a variety of fungal infections.
  • F. None of above.

Provenance (1 batch)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69f224c811508190a7de096a5b1f5798 completed April 29, 2026, 3:33 p.m.
Created at: April 29, 2026, 8:58 p.m.